Drugs / Anatabine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02432313 | Jan → Oct 2015 | — | Rock Creek Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anatabine | “Safety, Tolerability, and Pharmacokinetics of Modified and Immediate Release Anatabine Citrate Formulations” NCT02432313 ↗ |